After a few passages of in vitro culture, primary human articular chondrocytes undergo senescence and loss of their phenotype. Most of the available chondrocyte cell lines have been obtained from cartilage tissues different from diarthrodial joints, and their utility for osteoarthritis (OA) research is reduced. Thus, the goal of this research was the development of immortalized chondrocyte cell lines proceeded from the articular cartilage of patients with and without OA. Using telomerase reverse transcriptase (hTERT) and SV40 large T antigen (SV40LT), we transduced primary OA articular chondrocytes. Proliferative capacity, degree of senescence, and chondrocyte surface antigen expression in transduced chondrocytes were evaluated. In addition, the capacity of transduced chondrocytes to synthesize a tissue similar to cartilage and to respond to interleukin (IL)-1β was assessed.Aims
Methods
The reasons for the revisions were 20 aseptic cup loosenings and 20 cases of worn polyethylene, with presence of femoral osteolysis. Thirty of the stems were biological, nine mini-madreporic and one cemented. The mean follow-up was 5 years and 2 months. We used morsellised impacted bone graft held in place with cement, metal laminas or bone stock.
All the grafts took. There was very limited partial resorption in 20% of the cases and radiolucent lines in 20.6%. Among the complications were two new cases of wear with osteolysis and a fractured femur caused by a fall, with no infection or dislocation.
Impacted morsellised bone grafts in the femoral canal with a fixed stem, even with extensive, unchecked osteolysis, held in place with metal cages are a reliable means of recovering bone stock and holding the femoral component firmly in place for the long term, with good clinical and radiological outcome, minimal risk and shorter surgery.